This bill focuses on higher education funding for amyotrophic lateral sclerosis (ALS) research in Minnesota. It cancels a previous appropriation of $15,000,000 from the general fund that was designated for ALS research and instead appropriates the same amount to the Board of Regents of the University of Minnesota for a collaborative partnership with the Mayo Clinic. This funding is intended to support ongoing research aimed at improving the lives of individuals with ALS and finding a cure for the disease. The bill specifies that this is a one-time appropriation and that unencumbered balances will not cancel until June 30, 2029.

Additionally, the bill requires the Board of Regents to submit annual reports to the legislature starting January 15, 2026, detailing how the appropriated funds have been utilized in the collaborative research efforts. Furthermore, the bill repeals the previous legal language from Laws 2022, chapter 42, section 2, which outlined earlier appropriations and grant programs for ALS research, thereby streamlining the funding process under the new provisions.